Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis

Drug and therapies currently used to treat human bone diseases have a lot of severe side effects. Liquiritigenin is a flavonoid extracted from Glycyrrhiza glabra roots which has been reported to have positive effects in vitro on osteoblasts activity and bone mineralization as well as inhibitory effe...

Full description

Bibliographic Details
Main Authors: Marta Carnovali, Giuseppe Banfi, Massimo Mariotti
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861320300566